Description
RADIOPHARMACEUTICALS, DEOBLIGATE EXCESS FUNDS TO CLOSEOUT
Base award description: RADIOPHARMACEUTICALS
Modification chain · 9 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2013-10-03+$64,000= $64,000
- Mod P000012013-12-04+$25,598= $89,598
- Mod P000022014-01-22+$9,870= $99,467
- Mod P000032014-02-01+$50,000= $149,467
- Mod P000042014-04-08+$8,231= $157,698
- Mod P000052014-06-02+$52,796= $210,494
- Mod P000062014-07-01+$39,877= $250,371
- Mod P000072014-09-18+$18,585= $268,957
- Mod P000082015-01-02-$1,959= $266,997
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2013-10-03 | +$64,000 | $64,000 | RADIOPHARMACEUTICALS |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2013-12-04 | +$25,598 | $89,598 | RADIOPHARMACEUTICALS |
| Mod P00002· FUNDING ONLY ACTION | 2014-01-22 | +$9,870 | $99,467 | RADIOPHARMACEUTICALS |
| Mod P00003· FUNDING ONLY ACTION | 2014-02-01 | +$50,000 | $149,467 | RADIOPHARMACEUTICALS |
| Mod P00004· FUNDING ONLY ACTION | 2014-04-08 | +$8,231 | $157,698 | RADIOPHARMACEUTICALS |
| Mod P00005· FUNDING ONLY ACTION | 2014-06-02 | +$52,796 | $210,494 | RADIOPHARMACEUTICALS |
| Mod P00006· FUNDING ONLY ACTION | 2014-07-01 | +$39,877 | $250,371 | RADIOPHARMACEUTICALS |
| Mod P00007· FUNDING ONLY ACTION | 2014-09-18 | +$18,585 | $268,957 | RADIOPHARMACEUTICALS |
| Mod P00008· CLOSE OUT | 2015-01-02 | −$1,959 | $266,997 | RADIOPHARMACEUTICALS, DEOBLIGATE EXCESS FUNDS TO CLOSEOUT |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NRMNYAAVZ767)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25522N0051 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $7,678 | FY2022 |
| 36C25521N0048 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $145,047 | FY2021 |
| 36C24120N0016 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $368,096 | FY2020 |
| 36C25519N0519 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $134,688 | FY2019 |
| 36C24419P0012 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $30,306 | FY2019 |
| 36C24819N0033 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $125,065 | FY2019 |
Other recipients under 6505 from 250-NETWORK CONTRACT OFFICE 10 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25016P0864 | MCKESSON CORPORATION | 250-NETWORK CONTRACT OFFICE 10 | $10,571 | FY2016 |
| VA25016P0855 | MCKESSON CORPORATION | 250-NETWORK CONTRACT OFFICE 10 | $10,571 | FY2016 |
| VA25016P0838 | MCKESSON CORPORATION | 250-NETWORK CONTRACT OFFICE 10 | $16,913 | FY2016 |
| VA25016F0788 | CSL BEHRING L.L.C. | 250-NETWORK CONTRACT OFFICE 10 | $10,626 | FY2016 |
| VA25016F0783 | CSL BEHRING L.L.C. | 250-NETWORK CONTRACT OFFICE 10 | $7,279 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25014P0155_3600_-NONE-_-NONE- · retrieved 2026-09-26.